MAZAKALI CEO Sumit Mehta authored a recent News Media online article titled “Cannabis = Indian Medicine, Is One of Humankind’s Most Ancient Healing Herbs.” MAZAKALI is a cannabis-focused fintech marketplace that offers full-scale digital capital raising and investment services across the cannabis complex, including hemp, real estate, supply chain, ancillary and international. In the article, Mehta explains that more than 100 medical applications of cannabis were recorded as far back as 2737 by the father of Chinese medicine, Emperor Shen Nung. Uses for the substance have continued to increase, with scientists in 1992 identifying a previously undiscovered regulation system within the human body, the endocannabinoid system (“ECS”), which is a collection of cell receptors responsible for maintaining internal homeostasis, or stable balance, through the synthesis of cannabinoids — the same chemical compounds found in the cannabis plant — that are produced by the body. Today, one of the most common uses for medical cannabis is for pain control, although many are eyeing the plant as potential treatment for many of the same illnesses it was used for thousands of years ago. “The world is once again recognizing cannabis as safer than opiates (it is not possible to overdose and is less addictive than caffeine) and as a replacement for modern pain medication,” Mehta writes in the article. “Two recent studies published in the 110-year-old medical journal JAMA Internal Medicine indicate the rate of opiate prescriptions is lower in states where medical cannabis laws have been passed. The U.S. National Library of Medicine lists over 90 active studies currently being done in the space of cannabis medicine and directed toward the 500+ known compounds found in the plant.”
For more information, visit https://ibn.fm/Xp4OM
About MAZAKALI
Headquartered in San Francisco, MAZAKALI offers its Digital Capital Investment Platform to the global cannabis complex. Registered Investment Advisors customize investment portfolios via MAZAKALI’s Outsourced Cannabis Investment Officer (“OCIO”) service, and licensed Investment Bankers help operators with capital and M&A services. MAZAKALI’s leadership team began putting cannabis capital to work in 2014 and brings more than 150 years of financial, strategic, legal, compliance and international business experience to clients across the global hemp and nonhemp cannabis (“NHC”) industries. The MAZAKALI GreenPaper(R) has gained authority through knowledge on deep trends in the industry that matter to investors and operators alike. Securities are offered via a licensed broker/dealer. MAZAKALI was founded to counteract the negative consequences of business practices that deplete resources by making investments in sustainable hemp and nonhemp cannabis. By shepherding capital in a responsible and ethical manner, MAZAKALI and its clients envision a world where cannabis capital investment will play a significant role Beyond Impact.
NOTE TO INVESTORS: The latest news and updates relating to MAZAKALI are available in the company’s newsroom at https://ibn.fm/MAZAKALI
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.investorwire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork.